Metformin reduces overall cancer risk in patients with Type 2 diabetes
A commonly prescribed diabetes drug, metformin , reduces the overall cancer risk in people with Type 2 diabetes , a large systematic review study finds.
View full post on Mexico News
Leave a Reply